Australia, New Zealand Postpone Plans For Joint Medicines Agency
This article was originally published in PharmAsia News
Executive Summary
Australia and New Zealand's plan to establish a joint agency to regulate therapeutic products has been shelved after New Zealand lawmakers failed to support legislation to approve the country's participation in the venture
You may also be interested in...
Industry Could Help Asia Establish Adverse Event Monitoring Systems – DIA Conference
As countries like India and China reform their pharmacovigilance systems, opportunities are increasing for improved relationships between international companies and regulatory authorities despite stagnant harmonization efforts
Industry Could Help Asia Establish Adverse Event Monitoring Systems – DIA Conference
As countries like India and China reform their pharmacovigilance systems, opportunities are increasing for improved relationships between international companies and regulatory authorities despite stagnant harmonization efforts
Australia, New Zealand Request Comments On Joint Regulatory Agency
Australia and New Zealand are requesting comments on their proposal to establish a joint agency to regulate therapeutic products, including medicine scheduling provisions proposed for the agency